drugset / Trial / NCT04996134

Domperidone Expanded Access Treatment Program

NCT04996134 ↗

Expanded access No longer available Wake Forest University Health Sciences

Summary

To allow the use of domperidone by patients with gastrointestinal disorders who have failed standard therapy.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown 10 mg Oral
Subject Domperidone Unknown 30 mg Oral

Indications